Literature DB >> 20306157

The prevalence of the mutation in codon 249 of the P53 gene in patients with hepatocellular carcinoma (HCC) in Turkey.

Filiz Türe Ozdemir1, Arzu Tiftikci, Seda Sancak, Fatih Eren, Veysel Tahan, Hakan Akın, Feyza Gündüz, Ala Eldeen Kedrah, Yücel Ustündağ, Erol Avşar, Nurdan Tözün, Osman Ozdoğan.   

Abstract

UNLABELLED: Hepatocellular carcinoma (HCC) is one of the most common cancers in the worldwide. Aflotoxins, products of Aspergillus Flavus found in the high humidity environments induce HCC in humans by causing mutations in oncogenes such as codon 249 mutation of p53 in hepatocytes. In turkey, aflatoxins are found to be increased in some foods in certain areas, such as Istanbul which have high humidity. In present study we aimed to look for the prevalence of codon 249 mutation of p53 in patients with HCC, cirrhosis and chronic hepatitis B (CHB).
METHODS: DNA was extracted from plasma and mutation was detected by PCR-RFLP method.
RESULTS: the codon 249 mutation of p53 is found one out of 50 HCC (2%) patients. In conclusion, although codon 249 mutation of p53 gene has been found very rare but it exists showing the effect of aflatoxins in HCC patients in Turkey.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20306157     DOI: 10.1007/s12029-010-9140-5

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  36 in total

1.  XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency.

Authors:  R M Lunn; R G Langlois; L L Hsieh; C L Thompson; D A Bell
Journal:  Cancer Res       Date:  1999-06-01       Impact factor: 12.701

2.  p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.

Authors:  R M Lunn; Y J Zhang; L Y Wang; C J Chen; P H Lee; C S Lee; W Y Tsai; R M Santella
Journal:  Cancer Res       Date:  1997-08-15       Impact factor: 12.701

3.  Plasma 249Ser p53 mutation in patients with hepatocellular carcinoma residing in a high risk area.

Authors:  Lu Dong-Dong; Zhang Xi-Ran
Journal:  J Cell Mol Med       Date:  2003 Jan-Mar       Impact factor: 5.310

4.  Codon 249 mutation in exon 7 of p53 gene in plasma DNA: maybe a new early diagnostic marker of hepatocellular carcinoma in Qidong risk area, China.

Authors:  Xing-Hua Huang; Lu-Hong Sun; Dong-Dong Lu; Yan Sun; Li-Jie Ma; Xi-Ran Zhang; Jian Huang; Long Yu
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

5.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

6.  p53 mutations in british patients with hepatocellular carcinoma: clustering in genetic hemochromatosis.

Authors:  G Vautier; A B Bomford; B C Portmann; E Metivier; R Williams; S D Ryder
Journal:  Gastroenterology       Date:  1999-07       Impact factor: 22.682

7.  Microsatellite alterations in plasma DNA of small cell lung cancer patients.

Authors:  X Q Chen; M Stroun; J L Magnenat; L P Nicod; A M Kurt; J Lyautey; C Lederrey; P Anker
Journal:  Nat Med       Date:  1996-09       Impact factor: 53.440

Review 8.  Primary liver cancer: worldwide incidence and trends.

Authors:  F Xavier Bosch; Josepa Ribes; Mireia Díaz; Ramon Cléries
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

9.  Mutational hotspot in the p53 gene in human hepatocellular carcinomas.

Authors:  I C Hsu; R A Metcalf; T Sun; J A Welsh; N J Wang; C C Harris
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

10.  Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China.

Authors:  Y Fujimoto; L L Hampton; P J Wirth; N J Wang; J P Xie; S S Thorgeirsson
Journal:  Cancer Res       Date:  1994-01-01       Impact factor: 12.701

View more
  4 in total

Review 1.  DNA markers in molecular diagnostics for hepatocellular carcinoma.

Authors:  Ying-Hsiu Su; Selena Y Lin; Wei Song; Surbhi Jain
Journal:  Expert Rev Mol Diagn       Date:  2014-08-07       Impact factor: 5.225

2.  Hepatitis B and Hepatitis C Infection Biomarkers and TP53 Mutations in Hepatocellular Carcinomas from Colombia.

Authors:  Maria-Cristina Navas; Iris Suarez; Andrea Carreño; Diego Uribe; Wilson Alfredo Rios; Fabian Cortes-Mancera; Ghyslaine Martel; Beatriz Vieco; Diana Lozano; Carlos Jimenez; Doriane Gouas; German Osorio; Sergio Hoyos; Juan Carlos Restrepo; Gonzalo Correa; Sergio Jaramillo; Rocio Lopez; Luis Eduardo Bravo; Maria Patricia Arbelaez; Jean-Yves Scoazec; Behnoush Abedi-Ardekani; Regina M Santella; Isabelle Chemin; Pierre Hainaut
Journal:  Hepat Res Treat       Date:  2011-10-31

3.  Expression of P62 in hepatocellular carcinoma involving hepatitis B virus infection and aflatoxin B1 exposure.

Authors:  Xiao Xiang; Hong-Gui Qin; Xue-Mei You; Yan-Yan Wang; Lu-Nan Qi; Liang Ma; Bang-De Xiang; Jian-Hong Zhong; Le-Qun Li
Journal:  Cancer Med       Date:  2017-09-21       Impact factor: 4.452

Review 4.  It takes a team: a gain-of-function story of p53-R249S.

Authors:  Huai Wang; Peng Liao; Shelya X Zeng; Hua Lu
Journal:  J Mol Cell Biol       Date:  2019-04-01       Impact factor: 8.185

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.